Gain Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. 

CEO
Gene C. Mack
CEOGene C. Mack
Employees
21
Employees21
Headquarters
Bethesda, Maryland
HeadquartersBethesda, Maryland
Founded
2017
Founded2017
Employees
21
Employees21

GANX Key Statistics

Market cap
83.11M
Market cap83.11M
Price-Earnings ratio
-3.25
Price-Earnings ratio-3.25
Dividend yield
Dividend yield
Average volume
2.14M
Average volume2.14M
High today
$2.03
High today$2.03
Low today
$1.89
Low today$1.89
Open price
$1.99
Open price$1.99
Volume
769.11K
Volume769.11K
52 Week high
$4.34
52 Week high$4.34
52 Week low
$1.41
52 Week low$1.41

Stock Snapshot

As of today, Gain Therapeutics(GANX) shares are valued at $1.90. The company's market cap stands at 83.11M, with a P/E ratio of -3.25.

As of 2026-07-02, Gain Therapeutics(GANX) stock has fluctuated between $1.89 and $2.03. The current price stands at $1.90, placing the stock +0.8% above today's low and -6.4% off the high.

The Gain Therapeutics(GANX)'s current trading volume is 769.11K, compared to an average daily volume of 2.14M.

In the last year, Gain Therapeutics(GANX) shares hit a 52-week high of $4.34 and a 52-week low of $1.41.

In the last year, Gain Therapeutics(GANX) shares hit a 52-week high of $4.34 and a 52-week low of $1.41.

People also own

Based on the portfolios of people who own GANX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.